BMO Capital Positive on Horizon Pharma (HZNP) Amid CVS/Caremark News; Affirms at 'Outperform'

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/2/2026

1. NKE
2. TSLA
3. MU
4. SPY
5. SPCX
6. META
7. ABVX
8. NVDA
9. BE
10. STZ

Go back to BMO Capital Positive on Horizon Pharma (HZNP) Amid CVS/Caremark News; Affirms at 'Outperform'

CVS, Express Scripts 2017 Formulary Exclusion Lists Make Waves

August 2, 2016 11:56 AM EDT

On Monday, CVS Health (NYSE: CVS) released its 2017 Standard Formulary Exclusion List and Express Scripts (NASDAQ: ESRX) released its 2017 National Preferred Formulary exclusion list.

Below is a summary of analyst commentary around the list changes:

CVS 2017 Standard Formulary Exclusion List:

Barclays analyst Eric Percher said most notably, CVS signaled aggressively on biosimilars, replacing Neupogen with Zarxio (limited impact under the pharmacy benefit) and Lantus with Basaglar for 2017 (significant impact under the pharmacy benefit)

Percher noted a therapeutics focus on Oncology,... More

Horizon Pharma (HZNP): Contracting Activity Picking Up - Mizuho

August 2, 2016 9:51 AM EDT

Mizuho Securities analyst, Irina Koffler, reiterated her Outperform rating on shares of Horizon Pharma (NASDAQ: HZNP). The analyst believes that contracting activity is likely to pick up in the back half of the year. Yesterday during market hours, the release of the 2017 Express Scripts exclusion list, followed by the CVS/Caremark... More

Horizon Pharma (HZNP) Says DUEXIS and VIMOVO Will be Covered by CVS/Caremark

August 2, 2016 7:13 AM EDT

Horizon Pharma (NASDAQ: HZNP) disclosed the following on Tuesday morning:

Item 7.01 Regulation FD Disclosure.

Horizon Pharma has secured covered status for DUEXIS and VIMOVO with CVS/Caremark. The Company has been informed that beginning January 1, 2017, DUEXIS and VIMOVO will be removed from the CVS/Caremark exclusion list.

... More